Monday, October 26, 2026 · Daily editionET --:--:--

Looking for volunteers

A Study to Validate the Safety and Feasibility of ArtiSential in Colorectal Cancer Surgery Using Prospectively Constructed Multi-center Registry

NCT05566249 · Samsung Medical Center · Updated 6 Oct 2022

What is being tested
ArtiSential
For
Rectal Cancer; Rectosigmoid Cancer; Rectosigmoid Junction Cancer
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 80 years. About 1,000 people. The full rules are on the registry page.
Where
South Korea
When
Starts or started 1 Oct 2022, ends 31 Dec 2029. Registered 4 Oct 2022.
Results
None posted yet.

In the researchers' words

This study is to validate the safety and feasibility of ArtiSential (Articulating laparoscopic instrument) colorectal surgery and compare it with robotic surgery for patients with rectal cancer and rectosigmoid junction cancer.
ClinicalTrials.gov, NCT05566249

Sites

  • Samsung Medical CenterSeoul, South Korea